ÎçÒ¹¸£Àû1000¼¯ºÏ

Technology

Bioterror special: Friend or foe?

By Michael Reilly and Peter Aldhous

11 October 2006

TWEAKING the anthrax toxin to render experimental drugs ineffective. Turning a harmless rodent virus into a deadly pathogen. Enhancing the potency of botulinum toxins – already the most lethal poisons known. Transferring genes that help viruses evade the human immune system from one pathogen to another.

These projects may sound like the clandestine activities of a hostile bioweapons programme. But in fact, all are in progress or being planned in US academic labs. They were identified by New Scientist in a database that documents research funded by the US Department of ÎçÒ¹¸£Àû1000¼¯ºÏ and Human Services (DHHS). And while each project…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, today with our introductory offers

or

Existing subscribers

Sign in to your account
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop